- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 27.06. | Bone Biologics Prices $5 Mln Public Offering With Warrants At $4 Per Share | 1 | RTTNews | ||
| 27.06. | Why Is Bone Biologics Stock Surging On Friday? | 4 | Benzinga.com | ||
| 27.06. | Bone Biologics prices $5M public offering with warrants; shares up 45% | 1 | Seeking Alpha | ||
| 27.06. | Why Bone Biologics Is Rising In Pre-market? | 2 | RTTNews | ||
| 26.06. | Bone Biologics Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 26.06. | Bone Biologics regains Nasdaq compliance with minimum bid price rule; shares down | 1 | Seeking Alpha | ||
| 24.06. | Bone Biologics files $35M mixed shelf offering | 7 | Seeking Alpha | ||
| 24.06. | Bone Biologics Corp - S-1, General form for registration of securities | 2 | SEC Filings | ||
| BONE BIOLOGICS Aktie jetzt für 0€ handeln | |||||
| 06.06. | Bone Biologics plunges after announcing 1-for-6 reverse stock split | 2 | Seeking Alpha | ||
| 06.06. | Bone Biologics kündigt Aktienzusammenlegung im Verhältnis 1:6 an | 2 | Investing.com Deutsch | ||
| 06.06. | Bone Biologics announces 1-for-6 reverse stock split | 1 | Investing.com | ||
| 06.06. | Bone Biologics Corporation Announces 1-for-6 Reverse Stock Split | 908 | Business Wire | TYSONS CORNER, Va.--(BUSINESS WIRE)--Strategy (Nasdaq: MSTR/STRK/STRF) today announced the pricing of its initial public offering on June 5, 2025 of 11,764,700 shares of 10.00% Series A Perpetual Stride... ► Artikel lesen | |
| 30.05. | Aktionäre von Bone Biologics genehmigen wichtige Vorschläge | - | Investing.com Deutsch | ||
| 30.05. | Bone Biologics Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 12.05. | Bone Biologics Corp - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 01.04. | Bone Biologics Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 26.02. | Bone Biologics Corp - 10-K, Annual Report | 1 | SEC Filings |
17 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SERNOVA BIOTHERAPEUTICS | 0,115 | -3,36 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes | LONDON, Ontario, July 09, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics ("Sernova") (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH) today announced a Collaborative Research Agreement with Eledon Pharmaceuticals... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,680 | +2,72 % | Atossa Therapeutics Inc: Atossa Therapeutics Announces Second Quarter 2025 Financial Results and Provides a Corporate Update | FDA Provides Positive Feedback, Clears Path for Atossa to File IND for (Z)-Endoxifen in Metastatic Breast Cancer; FDA Indicates No Additional Toxicity Studies Required
Strong... ► Artikel lesen | |
| PING AN HEALTHCARE | 1,550 | +6,31 % | HSI Closes Midday at 24,929, Up 22 pts; HSTI Closes Midday at 5,438, Down 21 pts; KUAISHOU-W Down over 6%; CH MODERN D, BRILLIANCE CHI, YOURAN DAIRY, PA GOODDOCTOR, REALORD GROUP Hit New Highs | ||
| MOUNTAIN VALLEY MD | 0,012 | -6,06 % | Mountain Valley MD Holdings Inc: Mountain Valley appoints Batchelor as director | ||
| CO-DIAGNOSTICS | 0,208 | -4,59 % | Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results | SALT LAKE CITY, March 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the... ► Artikel lesen | |
| CYTOSORBENTS | 0,950 | +3,60 % | Cytosorbents Corp: CytoSorbents Reports Second Quarter 2025 Financial Results and Provides Business Update | PRINCETON, N.J., Aug. 7, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive... ► Artikel lesen | |
| VERU | 0,298 | 0,00 % | XFRA ISIN CHANGE | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenCA8959792018 Trilogy AI Corp. 08.08.2025 CA88909Q1090 Tokenwell Platforms Inc. 11.08.2025 Tausch 1:1US92536C1036 Veru... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Reports Second Quarter 2025 Financial Results and Provides Business Update | Received clearance to proceed with pivotal trial of amezalpat combination therapy for first-line hepatocellular carcinoma (HCC) in ChinaGranted orphan drug designation from the European Medicines... ► Artikel lesen | |
| VOLITIONRX | 0,668 | 0,00 % | VolitionRx - Nu.Q advances in lung cancer management | Despite rapid advancements in cancer treatments, effective diagnostics for early screening and disease monitoring continue to be an unmet need. This is felt acutely in lung cancer, which is the leading... ► Artikel lesen | |
| EKSO BIONICS | 2,910 | 0,00 % | Ekso Bionics Holdings, Inc.: Ekso Bionics Reports Second Quarter 2025 Financial Results | SAN RAFAEL, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) ("Ekso Bionics" or the "Company"), an industry leader in exoskeleton technology for medical and industrial... ► Artikel lesen | |
| IMUNON | 5,990 | +1,53 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 06.08.2025 | Das Instrument 9YG NO0010955917 DEEP VAL.DRILL.AS NK -,10 EQUITY wird cum Kapitalmassnahme gehandelt am 06.08.2025 und ex Kapitalmassnahme am 07.08.2025 The instrument 9YG NO0010955917 DEEP VAL.DRILL.AS... ► Artikel lesen | |
| BEYOND AIR | 3,160 | 0,00 % | Beyond Air: Umsatzsprung bei deutlicher Gewinnverfehlung | ||
| AVINGER | 0,465 | -22,17 % | NSE - Avinger Inc - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| NOVACYT | 0,443 | +4,86 % | Novacyt S.A. - Liquidity Agreement Monthly Update & TVR | ||
| AROVELLA THERAPEUTICS | 0,058 | +9,52 % | AROVELLA THERAPEUTICS LIMITED: Notice Under Section 708A |
BONE BIOLOGICS CORP gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 2,320 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BONE BIOLOGICS CORP finden Sie auf Wallstreet Online.